Home › Insider buying › NBIX

Neurocrine Biosciences Inc (NBIX): insider trading, Congress trades & who owns it

By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Insider signal
40/100
Insider selling · 90 days
Insider buys
$0
0 buyers · 12 months
Insider sales
$77.9M
15 sellers · 12 months
Funds holding
775
13F · Q2 2026
Congress trades
2
1 member · 2 years

Insider activity at Neurocrine Biosciences Inc has been all selling for a year now: about $77.9 million from 15 sellers, and zero buyers in open-market trades.

Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.

Zooming out by quarter: 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. 775 investment managers listed NBIX in their latest 13F filings (Q2 2026); more funds bought than sold. NBIX also shows up in congressional disclosures: 2 reported trades from one lawmaker in two years.

Want the full picture on NBIX? Financials, dilution history, a written bull & bear case, top holders and alerts.
See the full NBIX report — free account

Latest insider trades in NBIX

FiledInsiderRoleTypeSharesPriceValueSource
Sep 15, 2026Boyer David W.Executive OfficerSell826$157.45$130KSEC
Sep 15, 2026ABERNETHY MATTCFOSell2,311$157.20$363KSEC
Sep 10, 2026BENEVICH ERICExecutive OfficerSell2,154$154.61$333KSEC
Jul 30, 2026Norwalk Leslie VDirectorSell1,250$182.01$228KSEC
Jul 13, 2026Delaet IngridExecutive OfficerSell4,367$181.02$791KSEC
Jul 13, 2026Lippoldt DarinExecutive OfficerSell10,000$179.60$1.8MSEC
Jul 9, 2026Delaet IngridExecutive OfficerSell2,737$178.54$489KSEC
Jul 9, 2026Delaet IngridExecutive OfficerSell8,433$178.72$1.5MSEC
Jul 9, 2026Delaet IngridExecutive OfficerSell3,401$178.57$607KSEC
Jun 30, 2026Lippoldt DarinExecutive OfficerSell1,690$170.81$289KSEC
Jun 30, 2026Lippoldt DarinExecutive OfficerSell200$169.57$34KSEC
Jun 30, 2026Lippoldt DarinExecutive OfficerSell8,110$170.03$1.4MSEC
Jun 9, 2026SHERWIN STEPHEN ADirectorSell7,883$163.81$1.3MSEC
Jun 9, 2026SHERWIN STEPHEN ADirectorSell6,896$165.79$1.1MSEC
Jun 9, 2026SHERWIN STEPHEN ADirectorSell1,843$167.31$308KSEC

Congress trades in NBIX Free

FiledMemberTypeAmountSource
Aug 13, 2025Lisa C. McClain RSale (partial)$1,001 - $15,000Official filing
Aug 13, 2025Lisa C. McClain RPurchase$1,001 - $15,000Official filing

Questions about NBIX

Are insiders buying or selling NBIX stock?

In the last 12 months Neurocrine Biosciences Inc insiders made open-market purchases worth about $0 and sales worth about $77.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.

When was the last insider trade in NBIX?

The most recent open-market insider trade in NBIX was filed on 2026-09-15.

How many institutions own NBIX?

775 investment managers reported holding NBIX in SEC Form 13F filings for Q2 2026.

Has any member of Congress traded NBIX?

Yes. Members of Congress reported 2 trades in NBIX over the past two years. The full list is free on CapitalSnitch.

Also active in insider buying

GGRBBDCRBGBPREREFOPTUPRTAN.A.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.

Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).